Clik here to view.
Medtronic, Cochlear get in on $51m Earlens round
Earlens said today that it raised a funding round worth $51 million for the light-driven hearing aid it developed, pulling down $34 million in cash and another $17 million in a bridge financing...
View ArticleClik here to view.
CRO Medpace registers $150m IPO
Contract research organization Medpace last week registered for a $150 million initial public offering it plans to use to pay down some of its debt. Private equity shop Cinven paid CCMP Capital...
View ArticleClik here to view.
Accuray wins FDA nod for Radixact image-guided radiotherapy
Accuray (NSDQ:ARAY) said today it won FDA 510(k) clearance for its Radixact treatment delivery platform designed for image-guided radiotherapy treatments designed for cancer patients. The company said...
View ArticleClik here to view.
Report: CVRx CEO Yared tapped for AdvaMed chairman | Personnel Moves for June...
Report: CVRx CEO Yared tapped to succeed BD’s Forlenza as AdvaMed chairman Nadim Yared, the CEO of CVRx, is reportedly slated to replace Becton Dickinson (NYSE:BDX) chief executive Vincent Forlenza as...
View ArticleClik here to view.
HHS adds $8m, reups contract with Avita Medical
Avita Medical (ASX:AVH) said yesterday that the U.S. Department of Health and Human Services extended its contract with the company to the tune of an extra $8 million to support the U.S. market...
View ArticleClik here to view.
5 reasons the Brexit panic is overdone
Voters in the U.K. shocked the world last week when they voted to secede from the European Union. Investors around the globe reacted by sending share prices down nearly across the board – London’s FTSE...
View ArticleClik here to view.
BioVentrix wins CE Mark approval for Revivent TC heart failure device
Bioventrix said today it won CE Mark approval in the European Union for its Revivent TC transcatheter ventricular enhancement system designed to treat the left ventricle following a myocardial...
View ArticleClik here to view.
Boston Scientific logs Pa. reimbursement win for Alair asthma treatment
A private insurer in Pennsylvania is the latest to cover the Alair asthma treatment from Boston Scientific (NYSE:BSX). Philadelphia-based Independence Blue Cross said June 24 that it will cover the...
View ArticleClik here to view.
Spectral Medical wins compassionate use exemption for Toramyxicin
Spectral Medical said today it won compassionate use expanded access from the FDA for its Toraymyxin blood treatment device designed for removing endotoxins from patient’s blood. The Toraymyxin is an...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for June 27, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Baxter touts remote monitoring study for Amia dialysis device
Baxter (NYSE:BAX) today released the results from a study of its AMIA automated peritoneal dialysis system, touting the value of remote monitoring technology for chronic health conditions for improving...
View ArticleClik here to view.
What will Brexit mean for medical device companies?
By Ronald Boumans, Emergo Group In a stunning referendum on June 23, UK voters decided to leave the European Union (EU). This historic vote has many medical device companies – inside and outside the UK...
View ArticleClik here to view.
Entellus expands distribution deal with Fiagon to include hospitals
Entellus Medical said today it expanded its distribution agreement with Fiagon NA to purchase and resell Fiagon’s surgical navigation systems, components and parts in the U.S. and its territories to...
View ArticleClik here to view.
What makes good clinical research training?
We have noticed an increase in the demand for training across the clinical research landscape. This should come as no surprise with the constant advances in technology improving the way that clinical...
View ArticleClik here to view.
Important steps toward streamlining access to investigational drugs for...
By: Richard A. Moscicki, M.D. FDA is only too aware that there are many patients who have a serious or life-threatening medical condition for which there is no available FDA-approved therapy. For such...
View ArticleClik here to view.
West-Tech Materials named as MTD Micro Molding California sales group
MTD Micro Molding, a long-time leader in medical micro-injection molding, announced the appointment of West-Tech Materials as its sales representative organization for California. “I am very excited...
View ArticleClik here to view.
Mannkind taps medtech reps after Sanofi deal fails
Mannkind chief commercial officer Michael Castagna is trying to resuscitate the inhaled insulin maker after its co-marketing agreement with Sanofi (NYSE:SNY) was cancelled at the beginning of the year...
View ArticleClik here to view.
Wright Medical wants retrial in Conserve hip implant loss
Wright Medical (NSDQ:WMGI) wants a federal appeals court to overturn the verdict in the 1st bellwether trial over its Conserve metal-on-metal hip implant, arguing that a new trial is warranted because...
View ArticleClik here to view.
Medtronic launches Beacon HF monitoring service
Medtronic (NYSE:MDT) said today it launched its Beacon heart failure management service in the U.S., designed to monitor data from cardiac pacing devices to improve early interventions before heart...
View ArticleClik here to view.
Sweden’s Handicare acquires mobility device developer Prism Medical
Prism Medical said today that mobility and technical aid developer Handicare agreed to acquire it for approximately $62 million. Swedish Handicare, which supplies technical aids for the elderly and...
View Article